Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Arena Pharma: Using Options to Trade on FDA's Decision for Key Obesity Drug
Arena Pharma: Using Options to Trade on FDA's Decision for Key Obesity Drug
Arena Pharma: Using Options to Trade on FDA's Decision for Key Obesity Drug
Submitted by
admin
on August 27, 2010 - 11:10am
Source:
Seeking Alpha
News Tags:
Arena Pharmaceuticals
obesity
FDA
Vivus
Orexigen
Contrave
Qnexa
Headline:
Arena Pharma: Using Options to Trade on FDA's Decision for Key Obesity Drug
Do Not Allow Advertisers to Use My Personal information
